Prostacyclin prevents endothelial and platelet damage during dialysis.
D000941:Antigens / Q000032:analysis; D000990:Antithrombin III / Q000032:analysis*; D001161:Arteriosclerosis / Q000517:prevention & control; D001808:Blood Vessels / Q000473:pathology; D004727:Endothelium / Q000473:pathology; D011464:Epoprostenol / Q000627:therapeutic use*; D005169:Factor VIII / Q000032:analysis / Q000276:immunology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010976:Platelet Count; D011453:Prostaglandins / Q000627:therapeutic use*; D006435:Renal Dialysis / Q000009:adverse effects*; D014511:Uremia / Q000097:blood* / Q000473:pathology / Q000628:therapy; D001620:beta-Thromboglobulin / Q000032:analysis; D014841:von Willebrand Factor
D000941:Antigens; D011453:Prostaglandins; D001620:beta-Thromboglobulin; D014841:von Willebrand Factor; D000990:Antithrombin III; D005169:Factor VIII; D006493:Heparin; D011464:Epoprostenol